Advanced search
Publication Cover
Journal of Chemotherapy Volume 24, 2012 - Issue 4
Submit an article Journal homepage
78
Views
5
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus

Carlo TasciniU.O.C. Malattie Infettive, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
,
Sarah FlamminiU.O.C. Malattie Infettive, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
,
Alessandro LeonildiU.O.C. Malattie Infettive, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
,
Ilaria CiulloU.O.C. Malattie Infettive, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
,
Enrico TagliaferriU.O.C. Malattie Infettive, Azienda Ospedaliera Universitaria Pisana, Pisa, ItalyCorrespondence[email protected]
&
Francesco MenichettiU.O.C. Malattie Infettive, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
Pages 187-190 | Published online: 12 Nov 2013

References

  • Finch RG, Eliopoulos GM. Safety and efficacy of glycopeptide antibiotics. J Antimicrob Chemother. 2005;55 (Suppl. S2):ii5–13.
  • Beauregard DA, Williams DH, Gwynn MN, Knowles DJ. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob Agents Chemother. 1995;39:781–5.
  • Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother. 1996;37:209–22.
  • Bayer AS. Infective endocarditis. Clin Infect Dis. 1993;17:313–20.
  • Moise PA, Schentag JJ. Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents. 2001;16:31–4.
  • Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006;44:3883–6.
  • Campanile F, Bongiorno D, Borbone S, Stefani S. Hospital associated methicillin-resistant Staphylococcus aureus (HAMRSA) in Italy. Ann Clin Microbiol Antimicrob. 2009;8:22.
  • Musta AC, Riederer K, Shemes S, Chase P, Jose J, Johnson LB, et al.. Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years. J Clin Microbiol. 2009;47:1640–4.
  • European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.1. Basel, EUCAST; 2010.
  • Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. Volume 28, No. 1. Wayne, PA: CLSI; 2008.
  • Pantosti A, Sanchini A, Monaco M. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol. 2007;2:323–34.
  • Jones RN. Key considerations in the treatment of complicated staphylococcal infections. Clin Microbiol Infect. 2008;14(Suppl 2):3–9.
  • Henwood CJ, Livermore DM, Johnson AP, James D, Warner M, Gardiner A. Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group. J Antimicrob Chemother. 2000;46:931–40.
  • Cassone M, Campanile F, Pantosti A, Venditti M, Stefani S. Identification of a variant ‘Rome clone’ of methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin, responsible for an outbreak in an intensive care unit. Microb Drug Resist. 2004;10:43–9.
  • Marchese A, Balistreri G, Tonoli E, Debbia EA, Schito GC. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol. 2000;38:866–9.
  • Monaco M, Sanchini A, Grundmann H, Pantosti A, The EARSS-Italy S. aureus Typing Group. Vancomycin-heteroresistant phenotype in invasive methicillin-resistant Staphylococcus aureus isolates belonging to spa type 041. Eur J Clin Microbiol Infect Dis. 2010;29:771–7.
  • Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 2010;54:3861–70.
  • Hsu DI, Hidayat LK, Quist R, Hindler J, Karlsson A, Yusof A, et al.. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents. 2008;32:378–85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.